HemaCare https://validator.w3.org/feed/docs/rss2.html TROMBOSIS Anemia Mieloma Multiple Médicos Hemorragia + Coagulación Clara ¿Me salió alterado el hemograma, qué hago? Nosotros Patterns of presentation, treatment and survival in primary mediastinal B-cell lymphoma: a Colombian retrospective cohort Agendar Hemograma Claro Anemia Segunda Opinión Trombosis / Anticoagulación Segura Mujer & Gestación Hemato-Oncología Trasplante Adverse events associated with immune checkpoint inhibitors in a real-world Hispanic cohort: cardiovascular outcomes Pacientes Polatuzumab-vedotin in large diffuse B-cell lymphoma: a multicenter observational study from Latin America (2020–2024) Contacto Real-world incidence of thrombosis and cardiovascular adverse events with immune checkpoint inhibitors in a Hispanic population Inicio Análisis de la supervivencia de linfoma B difuso de célula grande tratado en Bogotá (2012–2014) Real-world data on brentuximab vedotin + bendamustine in relapsed/refractory Hodgkin lymphoma (centros colombianos) A novel digital educational strategy improves treatment adherence and quality of life in multiple myeloma A patient with HHV-8-positive multicentric Castleman’s disease meeting criteria for TAFRO syndrome Mejoramiento de la calidad de vida y adherencia al tratamiento en mieloma múltiple mediante estrategias educativas digitales Patterns and risk factors of infection and its impact on outcomes of newly diagnosed multiple myeloma Diagnóstico y tratamiento multidisciplinario del linfoma de células del manto: consenso de expertos (ACHO) Improving quality of life and treatment adherence in multiple myeloma patients using digital and spaced learning Aligning outcomes: DLBCL prognosis at a 4th-level university hospital in Bogotá comparable to high-income nations Characterization of Polycythemia Vera patients at high altitude: a retrospective study from Bogotá, Colombia Tumor infiltration and detection of plasma cells in bone marrow by flow cytometry, aspirate and biopsy Membranous glomerulopathy after autologous hematopoietic stem cell transplant in a patient with multiple myeloma